EDC for proof-of-concept trials: efficacy signals, safety, and 21 CFR Part 11–aligned controls in one platform.
21 CFR Part 11–aligned · HIPAA-aligned security · No credit card required
Proof-of-concept trials have unique design characteristics that your EDC needs to accommodate. Many POC studies use adaptive or response-adaptive designs, where the protocol may be modified based on interim data—adding or dropping treatment arms, adjusting dose levels, or modifying enrollment criteria. Capture handles these scenarios through its configuration-driven approach: study builders can modify visit schedules, add new CRF versions, and update edit checks without custom development, and every change is recorded in the audit trail with the reason for change. POC protocols frequently include biomarker-driven stratification, complex dosing windows, and mixed assessment types (clinician-rated scales, lab values, imaging endpoints, and patient-reported outcomes). Capture allows you to configure conditional logic within CRFs, so forms and fields appear based on prior responses, randomization arm, or visit type. This keeps the data entry experience clean for coordinators while ensuring that the underlying data model captures every protocol-required variable.
One of the greatest operational advantages of running your POC on Capture is the ability to carry your data infrastructure forward when the study succeeds. POC results that support a go decision typically require rapid transition into larger confirmatory trials, and teams that built their POC on a flexible platform can reuse CRF designs, consent templates, visit structures, and export formats as starting points for the next protocol. Capture enables this continuity by letting you clone study configurations and adapt them for new protocols. Your data team retains familiarity with the export structures, your sites already know the system, and your monitors can apply lessons learned from POC data quality directly to the next build. This reduces ramp-up time, training overhead, and the risk of introducing inconsistencies between studies that complicate portfolio-level analysis.
Data quality in proof-of-concept studies directly impacts the reliability of go/no-go decisions. Incomplete or inconsistent data can obscure efficacy signals or mask safety concerns, leading to flawed investment decisions. Capture addresses this through real-time data visibility, built-in edit checks, and integrated query management that keeps data clean from the point of entry. Monitors working on POC studies in Capture can review CRF data, run queries, and perform source data verification from a single interface. They see enrollment status, visit completion, and outstanding queries per site without needing a separate reporting tool. Medical monitors can review safety narratives and AE listings in the same system, with role-based views that show exactly the data relevant to their function. This transparency helps small POC teams maintain data standards that match those of larger, more heavily resourced programs.
Overview
Proof-of-concept (POC) clinical trials test whether a treatment shows early efficacy and acceptable safety in the target population. They occupy a pivotal position in drug development: strong POC results can justify the significant investment required to move into confirmatory Phase 2b or Phase 3 studies, while weak or ambiguous data may lead to asset termination or redesign. Because of these high stakes, the quality of data captured during a POC study must be impeccable—every efficacy endpoint, safety signal, and patient-reported outcome needs a complete, auditable record from enrollment through database lock. Your EDC must support efficacy and safety capture, potential randomization, flexible visit schedules, and protocol amendments with full auditability. Many POC designs also incorporate ePRO (electronic patient-reported outcomes) to complement clinician-assessed endpoints, adding another layer of data that needs seamless integration. At the same time, POC teams are typically smaller and more resource-constrained than late-phase programs, so the system must be practical to build, deploy, and maintain without requiring a dedicated IT department. Capture provides EDC, eConsent, ePRO, and safety in one platform with 21 CFR Part 11–aligned controls and HIPAA-aligned security. The platform is designed so that POC teams can collect high-quality, submission-ready data without enterprise overhead. From configurable CRFs and visit schedules to built-in randomization and electronic signatures, Capture gives proof-of-concept teams a single system that covers every operational need while keeping builds lean and amendments fast.
POC studies sit between early safety and confirmatory trials. You need efficacy and safety capture, sometimes randomization and ePRO, and the ability to amend as data emerges—without the full scope of a Phase 3 EDC. Unlike Phase 1 dose-escalation studies, POC protocols often involve randomized cohorts, placebo or active comparator arms, and stratified enrollment criteria. The data collected feeds directly into go/no-go investment decisions and may be included in regulatory briefing packages. At the same time, POC teams usually operate with a small staff—sometimes just one or two CRAs, a data manager, and a medical monitor. This means the EDC must be intuitive enough that site coordinators can enter data with minimal training, and monitors can review and query without navigating a complex, multi-module enterprise system. Protocol amendments are common in POC studies as interim data shapes the design; your EDC needs to handle form versioning, visit window changes, and consent updates cleanly, with a clear audit trail showing what changed and when. Capture supports POC with one platform, flexible build, and controls aligned with 21 CFR Part 11 for regulatory and sponsor confidence. Because Capture integrates EDC, eConsent, ePRO, and safety workflows in a single environment, your team avoids the integration headaches and data reconciliation tasks that come with patching together separate tools. This integrated approach also simplifies validation, since you are qualifying one system rather than three or four.
FAQ
Explore the platform with a free sandbox. No sales call required.